Equities Analysts Set Expectations for Revvity Q2 Earnings

Revvity Inc. (NYSE:RVTY) – Stock analysts at Leerink Partnrs upped their Q2 2025 EPS estimates for shares of Revvity in a research note issued on Thursday, July 17th. Leerink Partnrs analyst P. Souda now expects that the company will earn $1.15 per share for the quarter, up from their previous forecast of $1.14. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity’s FY2025 earnings at $4.94 EPS.

Revvity (NYSE:RVTY) last released its earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The firm’s quarterly revenue was up 2.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.98 earnings per share.

RVTY has been the subject of a number of other reports. Bank of America lowered their price target on Revvity from $116.00 to $110.00 and set a “buy” rating for the company in a research note on Thursday, June 26th. Wells Fargo & Company lowered their target price on shares of Revvity from $130.00 to $102.00 and set an “equal weight” rating for the company in a research note on Thursday, April 17th. Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a research report on Friday. JPMorgan Chase & Co. decreased their price target on shares of Revvity from $120.00 to $100.00 and set a “neutral” rating for the company in a report on Tuesday, April 29th. Finally, Barclays dropped their price objective on Revvity from $140.00 to $110.00 and set an “overweight” rating on the stock in a research note on Thursday, April 10th. Five equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, Revvity currently has an average rating of “Moderate Buy” and an average price target of $123.07.

Revvity Trading Down 2.5%

Shares of NYSE RVTY opened at $93.19 on Friday. Revvity has a fifty-two week low of $87.70 and a fifty-two week high of $129.50. The firm has a market capitalization of $10.98 billion, a P/E ratio of 39.66, a P/E/G ratio of 2.41 and a beta of 0.98. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.58 and a quick ratio of 2.99. The company’s 50 day simple moving average is $95.10 and its 200 day simple moving average is $103.97.

Hedge Funds Weigh In On Revvity

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RVTY. T. Rowe Price Investment Management Inc. grew its holdings in Revvity by 8.5% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company’s stock valued at $2,382,163,000 after buying an additional 1,754,403 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Revvity by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company’s stock worth $1,521,705,000 after purchasing an additional 92,638 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Revvity by 25.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company’s stock worth $1,011,863,000 after purchasing an additional 1,932,314 shares during the period. Janus Henderson Group PLC raised its position in shares of Revvity by 0.4% in the fourth quarter. Janus Henderson Group PLC now owns 6,358,952 shares of the company’s stock valued at $709,725,000 after buying an additional 23,650 shares in the last quarter. Finally, EdgePoint Investment Group Inc. boosted its stake in shares of Revvity by 32.1% in the first quarter. EdgePoint Investment Group Inc. now owns 5,360,847 shares of the company’s stock valued at $567,178,000 after buying an additional 1,302,616 shares during the period. 86.65% of the stock is owned by institutional investors.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.30%. Revvity’s payout ratio is 11.91%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.